3.22
전일 마감가:
$3.07
열려 있는:
$3.16
하루 거래량:
2.02M
Relative Volume:
2.46
시가총액:
$49.81M
수익:
$18.94M
순이익/손실:
$-2.71M
주가수익비율:
-23.00
EPS:
-0.14
순현금흐름:
$-4.92M
1주 성능:
+92.81%
1개월 성능:
+38.20%
6개월 성능:
+65.13%
1년 성능:
+106.41%
Icad Inc Stock (ICAD) Company Profile
명칭
Icad Inc
전화
603-882-5200
주소
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
ICAD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ICAD
Icad Inc
|
3.22 | 49.81M | 18.94M | -2.71M | -4.92M | -0.14 |
![]()
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-01-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
2021-04-22 | 개시 | Guggenheim | Buy |
2021-03-23 | 개시 | BTIG Research | Buy |
2021-02-26 | 개시 | Oppenheimer | Outperform |
2021-01-29 | 개시 | Cantor Fitzgerald | Overweight |
2020-12-03 | 개시 | B. Riley Securities | Buy |
2020-02-05 | 개시 | JMP Securities | Mkt Outperform |
2020-01-09 | 개시 | Lake Street | Buy |
2008-12-09 | 재확인 | Canaccord Adams | Buy |
2008-08-01 | 재확인 | MDB Capital Group | Buy |
2008-05-14 | 재확인 | Canaccord Adams | Buy |
2008-02-14 | 개시 | Sun Trust Rbsn Humphrey | Buy |
2007-01-24 | 재확인 | Dawson James | Speculative Buy |
모두보기
Icad Inc 주식(ICAD)의 최신 뉴스
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of iCAD, Inc.ICAD - Eastern Progress
RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says - MarketScreener
RadNet’s DeepHealth strikes $103m deal to acquire iCAD - Medical Device Network
ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc.ICAD - MarketScreener
BTIG Research Downgrades iCAD to Neutral From Buy - MarketScreener
3 Promising Penny Stocks With Market Caps Under $200M - Yahoo Finance
iCAD (ICAD) Downgraded by BTIG Following Acquisition Announcement | ICAD Stock News - GuruFocus
This Microsoft Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
RadNet leaders discuss rationale behind blockbuster $103M iCAD AI acquisition - Radiology Business
iCAD (ICAD) Downgraded to Hold Following Acquisition Announcement | ICAD Stock News - GuruFocus
To speed adoption of breast cancer AI, a radiology network plots an acquisition - statnews.com
Laidlaw cuts ICAD stock rating following acquisition news By Investing.com - Investing.com UK
RadNet to acquire iCAD, expand AI breast imaging impact - IT Brief Australia
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA on Behalf of Shareholders - GlobeNewswire
BTIG cuts ICAD stock rating following RadNet acquisition plan By Investing.com - Investing.com South Africa
Radnet doubles down on breast cancer with $103M Icad buy - BioWorld MedTech
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Longevity Health Holdings, Inc. (NasdaqXAGE), iCAD, Inc. (NasdaqICAD), Beacon Roofing Supply, Inc. (NasdaqBECN), Dada Nexus Limited (NasdaqD - TradingView
iCAD (ICAD) Stock Downgraded to Neutral Amid RadNet Acquisition Plans | ICAD Stock News - GuruFocus
RadNet's Bold Move: Acquiring ICad In A $103 Million Deal - Finimize
RadNet Buying Breast Health Solutions Company iCAD - Healthcare Innovation
Top Midday Gainers - MarketScreener
RadNet to Acquire iCAD (ICAD) in $103M Stock Deal | ICAD Stock N - GuruFocus
RadNet to acquire iCad - MassDevice
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
RadNet to Acquire iCAD for $103 Million - Medical Product Outsourcing
Acquisition Announcement Sparks Buying Spree For This Micro Cap - The Globe and Mail
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Benzinga
Is Healthcare the Next AI Gold Rush? Analysts Are Paying Close Attention - Baystreet.ca
Top Premarket Gainers - MarketScreener
Truist maintains RadNet buy rating, $74 target amid iCAD deal By Investing.com - Investing.com UK
US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert - Benzinga
Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA, MESA on Behalf of Shareholders - PR Newswire
RadNet (RDNT) to Acquire iCAD in $103 Million Stock Deal - GuruFocus
ICAD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iCad, Inc. Is Fair to Shareholders - Bluefield Daily Telegraph
RadNet to acquire iCAD - Medical Buyer
RadNet to Acquire iCAD for $103M in All-Stock Transaction - HIT Consultant
RadNet to acquire AI cancer detection firm iCAD in stock deal - Investing.com Canada
iCAD (ICAD) Appoints Mark Koeniguer as Chief Commercial Officer - GuruFocus
RadNet to acquire AI cancer detection firm iCAD in stock deal By Investing.com - Investing.com South Africa
RadNet to acquire breast imaging AI vendor iCAD for $103M - Radiology Business
RadNet inks $103M deal to purchase iCAD - AuntMinnie
iCAD Announces Merger Agreement with RadNet - TipRanks
RadNet to acquire iCAD in $103 million all-stock deal focused on breast cancer AI - DOTmed
RadNet to Acquire iCad in $103 Million All-Stock Deal - MarketScreener
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Earl - GuruFocus
RadNet Announces Merger Agreement with iCAD - TipRanks
RadNet (RDNT) to Acquire iCAD in $103 Million All-Stock Deal | I - GuruFocus
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer - GlobeNewswire
Major AI Breakthrough: RadNet's $103M iCAD Acquisition Transforms Breast Cancer Detection - Stock Titan
RadNet to acquire iCAD; iCAD shares jump more than 70% - MSN
Icad Inc (ICAD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):